Transforming internal processes with technology

Cutting-edge biotech firm Oxford Nanopore Technologies (Oxford Nanopore) was looking for a better solution to document verification in light of its growing compliance burden. The usual process of manually tracking material statements in spreadsheets was made particularly difficult by the need to fact-check complex technical data and scientific visualisations.

Of particular focus was having a robust process around verifying their sustainability report. Regulatory expectations and growing stakeholder scrutiny on ESG disclosures have made it crucial for companies like Oxford Nanopore to demonstrate transparency in their environmental and social initiatives, and mitigate the risk of greenwashing.

Beyond lines of text

With Atticus, Oxford Nanopore now has a single platform to house all documents requiring verification, collate supporting evidence, identify key statements, and collaborate internally.

Oxford Nanopore’s team particularly loves the ability to verify technical graphs and diagrams, not just statements and numbers. Their newly streamlined workflow allows subject matter experts to begin adding evidence to claims much earlier in the process, saving time and reducing stress. 

The pain of version control

Handling changes to the document being verified is one of the more painful parts of verification. Oxford Nanopore’s legal team can now quickly hone in on what’s changed between turns of the document, side-stepping the need to have different versions emailed back and forth or work being duplicated. 

Looking ahead

One year in, the team at Oxford Nanopore is feeling ahead of the curve in addressing their reporting requirements. They look forward to further reducing risk and increasing efficiency as more business units adopt Atticus.

About Oxford Nanopore Technologies

Oxford Nanopore Technologies develops innovative DNA/RNA sequencing technology that is fast, accessible, and user-friendly, aiming to revolutionise biological analyses and enable impactful applications. Founded in 2005 as a University of Oxford spin-out, the company employs over 1,000 experts across diverse fields, including nanopore science and molecular biology. Headquartered at the Oxford Science Park, UK, it operates globally with offices in the US, Singapore, China, and a commercial presence in countries like Japan, Germany, and India. 

As a public company, it serves customers in over 120 countries, aiming to create meaningful societal advancements through its groundbreaking technologies.